Logo

Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles due to Packaging Issues

Share this

Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles due to Packaging Issues

Shots:

  • Sandoz recalls ~636-000 of Losartan potassium and Ezetimibe prescription drug bottles due to failure to meet child-resistant closure requirements as required by the Poison Prevention Packaging Act- posing a poisoning risk if swallowed by children
  • The products affected by the recall has distributed by Sandoz in the US includes Ezetimibe in 10mg tablets in 30 and 90 count bottles with its affected NDC numbers are # 0781-5690-31 (30 tablets) and # 0781-5690-92 (90 tablets) and Losartan potassium in 50mg in 30 count bottles with NDC number # 0781-5701-31
  • The affected lot was sold at clinics & pharmacies from Jul’18 to Aug’19. Consumers or pharmacies can contact Sandoz at  www.us.sandoz.com or 1-800-525-8747  for a free replacement child-resistant bottle cap and can continue the medication- once the medication is secured

Click here to­ read full press release/ article | Ref: PRNewswire | Image: WUSA9


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions